-
EP4429672
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP4429672
| Cited in | Search | Type: | Patent literature | Publication No.: | WO2020157569
[IY] (DIAMOND THERAPEUTICS INC et al.) [I] 1-3,7-14 * paragraphs [0266] , [ 268] *[Y] 1-3,7-14 | Type: | Non-patent literature | Publication information: | [IY] WILSON: "Gross behavioral and physiological effects of hallucinogens in conscious restrained monkeys", RESEARCH COMMUNICATIONS IN SUBSTANCES OF ABUSE, vol. 2, no. 2, 1 January 1981 (1981-01-01), pages 145 - 160, XP093256546 [I] 1-3,7-14 * page 148, paragraph last * * table 1 * [Y] 1-3,7-14 | Type: | Non-patent literature | Publication information: | [Y] SAMMETA VAMSHIKRISHNA REDDY ET AL: "The hydrochloride salt of 4-hydroxy- N , N -di- n -propyltryptamine (4-HO-DPT)", IUCRDATA, vol. 5, no. 11, 28 November 2020 (2020-11-28), pages 201546, XP055905709, Retrieved from the Internet | DOI: | http://dx.doi.org/10.1107/S2414314620015461 | Type: | Non-patent literature | Publication information: | [IY] DATABASE REAXYS [online] 25 January 2021 (2021-01-25), BREEKSEMA J: "Treatment with psilocybin: Applications for patients with psychiatric disorders", XP093256548, Database accession no. XRN = 37140626 [I] 4-7,9-14 * abstract *[Y] 4-7,9-14 | Type: | Non-patent literature | Publication information: | [IY] BREEKSMA J: "Treatment with psilocybin: applications for patients with psychiatric disorders", NED TIJDSCHR GENEESKD ., vol. 165, 25 January 2021 (2021-01-25), XP093256547, Retrieved from the Internet | Type: | Non-patent literature | Publication information: | [Y] "Handbook of Pharmaceutical Salts: Properties, Selection and Use", 1 January 2002, article STAHL P H: "Supplementary material - list of pharmaceutically acceptable acids", pages: 1 - 1, XP093259397 [Y] 4-7,9-14 * page 1, column 1 * | Cited in | International search | Type: | Patent literature | Publication No.: | WO2020157569
[X] (DIAMOND THERAPEUTICS INC et al.) [X] 15, 20 & 23-33 * Abstract; examples 1 & 2, page 85; pages 54, 56 & 64 * | Type: | Patent literature | Publication No.: | WO2020212948
[X] (COMPASS PATHFINDER LTD et al.) [X] 1-40 * Figures 2a-2e; pages 41-44 * | Type: | Patent literature | Publication No.: | WO2020212951
[X] (COMPASS PATHFINDER LTD et al.) [X] 1-40 * Figures 2a-2e; pages 41-43 * | Type: | Patent literature | Publication No.: | WO2020212952
[X] (COMPASS PATHFINDER LTD et al.) [X] 1-40 * Figures 2a-2e; pages 43-45 * | Type: | Patent literature | Publication No.: | GB941707
[X] (SANDOZ LTD et al.) [X] 41-69 & 71-85 * example 2, page 2; column 1, page2 * | Type: | Patent literature | Publication No.: | US2021292278
[X] (CHADEAYNE ANDREW R et al.) [X] 41-69 & 71-85 * Example 1 & 2, pages 4-5; paragraphs 32-39 * | Type: | Non-patent literature | Publication information: | [X] WEBER, H. P. ET AL.: "Crystal Structures of the Teonanacatl Hallucinogens. Part 1. Psilocybin C12H17N204P", JOURNAL OF THE CHEMICAL SOCIETY, PERKIN TRANSACTIONS 2: PHYSICAL ORGANIC CHEMISTRY, 1974, pages 942 - 6, XP002788002, DOI: 10.1039/P29740000942 [X] 15 * Page 942 * | DOI: | http://dx.doi.org/10.1039/P29740000942 | Type: | Non-patent literature | Publication information: | [X] GATCH, M. B. ET AL.: "Discriminative stimulus effects of substituted tryptamines in rats", ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, vol. 4, no. 2, 2021, pages 467 - 471, XP055924550, DOI: 10.1021/acsptsci.0c00173 [X] 41-44, 47, 60 & 64 * Drugs, page 470 * | DOI: | http://dx.doi.org/10.1021/acsptsci.0c00173 | Type: | Non-patent literature | Publication information: | [A] SINGHAL, D . ET AL.: "Drug polymorphism and dosage form design: a practical perspective", ADVANCED DRUG DELIVERY REVIEWS, vol. 56, 2004, pages 335 - 347, XP055049578, DOI: 10.1016/j.addr.2003.10.008 [A] 0 * The whole document * | DOI: | http://dx.doi.org/10.1016/j.addr.2003.10.008 | Type: | Non-patent literature | Publication information: | [A] MINO R. CAIRA: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY., SPRINGER, BERLIN., DE, vol. 198, 1 January 1998 (1998-01-01), DE , pages 163 - 208, XP001156954, ISSN: 0340-1022, DOI: 10.1007/3-540-69178-2_5 [A] 0 * The whole document * | DOI: | http://dx.doi.org/10.1007/3-540-69178-2_5 | Type: | Non-patent literature | Publication information: | [A] BALBACH, S. ET AL.: "Pharmaceutical evaluation of early development candidates", THE 100 MG APPROACH''', INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 275, 2004, pages 1 - 12, XP055263513, DOI: 10.1016/j.ijpharm.2004.01.034 [A] 0 * The whole document * | DOI: | http://dx.doi.org/10.1016/j.ijpharm.2004.01.034 |